171 related articles for article (PubMed ID: 33550242)
1. Study protocol for a single-centre non-inferior randomised controlled trial on a novel three-dimensional matrix positioning-based cognitive fusion-targeted biopsy and software-based fusion-targeted biopsy for the detection rate of clinically significant prostate cancer in men without a prior biopsy.
He B; Li R; Li D; Huang L; Wen X; Yang G; Wang H
BMJ Open; 2021 Feb; 11(2):e041427. PubMed ID: 33550242
[TBL] [Abstract][Full Text] [Related]
2. A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol.
Kasivisvanathan V; Jichi F; Klotz L; Villers A; Taneja SS; Punwani S; Freeman A; Emberton M; Moore CM
BMJ Open; 2017 Oct; 7(10):e017863. PubMed ID: 29025845
[TBL] [Abstract][Full Text] [Related]
3. Combined MRI-TRUS fusion targeted and systematic biopsy versus systematic biopsy alone for the detection of prostate cancer: protocol for a prospective single-centre trial.
Liu W; Kadier A; Shen D; He Y; Dong S; Zhu K; Xu G; Zhao B; Mao S; Guo C; Yao X; Wei Q; Han D; Yang B
BMJ Open; 2024 Mar; 14(3):e080593. PubMed ID: 38431292
[TBL] [Abstract][Full Text] [Related]
4. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
5. Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0).
Ettala O; Jambor I; Montoya Perez I; Seppänen M; Kaipia A; Seikkula H; Syvänen KT; Taimen P; Verho J; Steiner A; Saunavaara J; Saukko E; Löyttyniemi E; Sjoberg DD; Vickers A; Aronen H; Boström P
BMJ Open; 2022 Apr; 12(4):e053118. PubMed ID: 35428621
[TBL] [Abstract][Full Text] [Related]
6. Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol.
Asif A; Nathan A; Ng A; Khetrapal P; Chan VW; Giganti F; Allen C; Freeman A; Punwani S; Lorgelly P; Clarke CS; Brew-Graves C; Muirhead N; Emberton M; Agarwal R; Takwoingi Y; Deeks JJ; Moore CM; Kasivisvanathan V;
BMJ Open; 2023 Apr; 13(4):e070280. PubMed ID: 37019486
[TBL] [Abstract][Full Text] [Related]
7. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.
Valerio M; Donaldson I; Emberton M; Ehdaie B; Hadaschik BA; Marks LS; Mozer P; Rastinehad AR; Ahmed HU
Eur Urol; 2015 Jul; 68(1):8-19. PubMed ID: 25454618
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging/transrectal ultrasound fusion-targeted prostate biopsy using three-dimensional ultrasound-based organ-tracking technology: Initial experience in Japan.
Yamada Y; Fujihara A; Shiraishi T; Ueda T; Yamada T; Ueno A; Inoue Y; Kaneko M; Kamoi K; Hongo F; Okihara K; Ukimura O
Int J Urol; 2019 May; 26(5):544-549. PubMed ID: 30793385
[TBL] [Abstract][Full Text] [Related]
9. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
[TBL] [Abstract][Full Text] [Related]
10. The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years.
Meng X; Rosenkrantz AB; Huang R; Deng FM; Wysock JS; Bjurlin MA; Huang WC; Lepor H; Taneja SS
J Urol; 2018 Nov; 200(5):1022-1029. PubMed ID: 29886090
[TBL] [Abstract][Full Text] [Related]
11. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
[TBL] [Abstract][Full Text] [Related]
13. Impact of real-time elastography on magnetic resonance imaging/ultrasound fusion guided biopsy in patients with prior negative prostate biopsies.
Brock M; Löppenberg B; Roghmann F; Pelzer A; Dickmann M; Becker W; Martin-Seidel P; Sommerer F; Schenk L; Palisaar RJ; Noldus J; von Bodman C
J Urol; 2015 Apr; 193(4):1191-7. PubMed ID: 25451832
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy.
Lee AYM; Yang XY; Lee HJ; Law YM; Huang HH; Lau WKO; Lee LS; Ho HSS; Tay KJ; Cheng CWS; Yuen JSP; Chen K
BJU Int; 2020 Nov; 126(5):568-576. PubMed ID: 32438463
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate.
Costa DN; Goldberg K; Leon AD; Lotan Y; Xi Y; Aziz M; Freifeld Y; Margulis V; Raj G; Roehrborn CG; Hornberger B; Desai N; Bagrodia A; Francis F; Pedrosa I; Cadeddu JA
Eur Urol Oncol; 2019 Jul; 2(4):397-404. PubMed ID: 31277776
[TBL] [Abstract][Full Text] [Related]
16. A Comparison of Prostate Cancer Detection between Visual Estimation (Cognitive Registration) and Image Fusion (Software Registration) Targeted Transperineal Prostate Biopsy.
Khoo CC; Eldred-Evans D; Peters M; van Son M; van Rossum PSN; Connor MJ; Hosking-Jervis F; Tanaka MB; Reddy D; Bass E; Powell L; Ahmad S; Pegers E; Joshi S; Sri D; Wong K; Tam H; Hrouda D; Qazi H; Gordon S; McCracken S; Winkler M; Ahmed HU
J Urol; 2021 Apr; 205(4):1075-1081. PubMed ID: 33207137
[TBL] [Abstract][Full Text] [Related]
17. A multicentre parallel-group randomised trial assessing multiparametric MRI characterisation and image-guided biopsy of prostate in men suspected of having prostate cancer: MULTIPROS study protocol.
Szewczyk-Bieda M; Wei C; Coll K; Gandy S; Donnan P; Ragupathy SKA; Singh P; Wilson J; Nabi G
Trials; 2019 Nov; 20(1):638. PubMed ID: 31752954
[TBL] [Abstract][Full Text] [Related]
18. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging-guided targeted prostate biopsy: Comparison between computer-software-based fusion versus cognitive fusion technique in biopsy-naïve patients.
Yamada Y; Shiraishi T; Ueno A; Ueda T; Fujihara A; Naitoh Y; Hongo F; Ukimura O
Int J Urol; 2020 Jan; 27(1):67-71. PubMed ID: 31587386
[TBL] [Abstract][Full Text] [Related]
20. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
